Our goal is to facilitate Fukushima’s bright future through contributions to the reconstruction after the Great East Japan Earthquake disaster.
We are working to contribute to the reconstruction by establishing and promoting the pharmaceutical-related industries by working collaboratively with the Translational Research Center at Fukushima Medical University and its associated companies.
Link to Translational Research Center at Fukushima Medical University
Topics
We will provide Japanese Cancer Genome Analysis Data for a fee
-Whole Exome Sequence Analysis of Japanese patients with cancer performed in Fukushima Translational Research Project.
-Tumor-Normal pair analysis providing only Tumor-Specific Variants and no personally genomic information
-Unpublished variant data
-Obtained informed consent (IC) to be able to utilize for both domestic and foreign companies
-No restriction to the purpose to utilize data
-Exclusive contract for all data to use also available
A report on antibody profiling in blood of individuals recovering from COVID-19 is now available.
-We will present a report on antibody profiling in blood of COVID-19 recovering patients obtained in the Fukushima project.
-The raw data is also available freely.
Vision
- Conduct innovative research and engage in challenging development that meet the needs of medical care and patients with substantial expertise and a broad perspective on life sciences, healthcare, and medicine, through collaborations between industry, academia, and government
- Based on the “Fukushima Collection®,” achievements created in Fukushima, we continue to contribute to the reconstruction of Fukushima and at the same time, improve human health through the creation of new industries and the vitalization of life science-related industries
- Develop excellent human resources using life science-related technologies
Mission
- Contribute to the improvement of human health using proprietary life science technologies
- Create new industries based on the achievements created in Fukushima
- Aim for Fukushima’s bright future through contributions to its reconstruction after the Great East Japan Earthquake disaster
Project
Providing the Databases
F-PDO, F-PDX, and cancer cells
- Gene expressions
- Genomic analyses
- Anticancer drug sensitivity
- Clinical information
Conducting contract research using F-PDO, F-PDX, and cancer cell lines
We can also provide F-PDO and F-PDX.
(links to outlines of F-PDO and F-PDX)
Antibody profiling using a protein microarray
- Binding to human proteins
- Binding and cross-reactivity
Conducting contract testing using a protein microarray
Please contact us if you are interested.
(link to outlines of protein microarray)
Research and development consulting
Consulting for research and development work with databases and deliverables.
Greeting
At the Translational Research Center at Fukushima Medical University (TR center), we have been promoting the Fukushima Translational Research Project (Fukushima Project), launched as a part of the post-Great East Japan Earthquake reconstruction measures. The purpose of the Fukushima Project is to provide development support for pharmaceutical and medical testing/IVD industries and reagent manufacturers, as well as to create new biological industries and provide employment in Fukushima.
To ensure the stability of our project in the future, we established the Fukushima Translational Research Foundation on February 3, 2020. We will play a role in further promoting the transfer of the project’s research and development results (Fukushima Collection®) to industries, in fields where it is difficult for Fukushima Medical University to proactively utilize the results of research and development, by building a close working relationship with the TR center.
Through this project, we aim to support research and development for members and to create and accumulate pharmaceutical-related industries by working collaboratively with the TR center and TR center-initiated venture companies.
We would like to ask for your continual support and encouragement.
![](https://ftrf.jp/ftrf/wp-content/uploads/2020/04/iemura.jpg)
Chairman, Shun-ichiro Iemura
Link to Translational Research Center at Fukushima Medical University
Organization
Fukushima Translational Research Foundation
Chairman | Shun-ichiro Iemura |
Managing director | Toshiyuki Hayashi |
Vice-chairman | Jun-ichi Imai |
Director | Kiyoaki Katahira Yasuo Uchiyama Sigenobu Ohashi Yoshihiro Kanno |
Councilor | Seiichi Takenoshita Kiyoshi Saito Hatsuo Fujishima Takao Isogai |
Supervisor | Hitoshi Takuma |
Contact Us
Address: Capital Front Bldg. 7-4, 1-35, Sakaemachi, Fukushima City, Fukushima, 960-8031, Japan